“Reversal Reaction in A Borderline Lepromatous Leprosy Patient after COVID-19 Vaccine: Prevention or Risks?”, J Pak Assoc Dermatol, vol. 32, no. 3, pp. 609–612, Aug. 2022, doi: 10.66344/jpad.32.3.2022.1953.